By CapitalSnitch Research Desk · updated Oct 11, 2026 · data from SEC filings and official Congress disclosures
Silo Pharma, Inc. insiders have been one-way buyers this past year: one person put roughly $7,660 into the stock and nobody sold with their own money.
The largest purchase came from Weisblum Eric (CEO), about $3,000. C-suite participation is part of the picture here.
Quarter by quarter: No open-market insider buying or selling in the last full quarter. Insiders bought in 2 of the last 7 full quarters. 8 investment managers listed SILO in their latest 13F filings (Q2 2026); more funds bought than sold.
Are insiders buying or selling SILO stock?
In the last 12 months Silo Pharma, Inc. insiders made open-market purchases worth about $7,660 and sales worth about $0. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
When was the last insider trade in SILO?
The most recent open-market insider trade in SILO was filed on 2025-12-16.
How many institutions own SILO?
8 investment managers reported holding SILO in SEC Form 13F filings for Q2 2026.
Has any member of Congress traded SILO?
No congressional trades in SILO were reported in the past two years. The full list is free on CapitalSnitch.
Free weekly email: the week's biggest insider buys and Congress trades, every Monday. No spam, one-click unsubscribe.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1).
Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).